<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7102522/results/search/drug/results.xml">
  <result pre="replication: (Ab: Antibody; DPP4: Dipeptidase Peptidyl 4; TMPRSS2: Transmembrane Protease," exact="Serine" post="2; PLpro: Papain-like Protease; 3CLpro: 3-C-like Protease; RdRp: RNA"/>
  <result pre="anti-viral therapeutics used in patients with SARS and MERS infections." exact="Ribavirin" post="(1) has been widely used for treating a variety"/>
  <result pre="41, 44. On the other hand, the patients who received" exact="ribavirin" post="(1), lopinavir (10, see Fig. 4 )- ritonavir (2)"/>
  <result pre="On the other hand, the patients who received ribavirin (1)," exact="lopinavir" post="(10, see Fig. 4 )- ritonavir (2) and a"/>
  <result pre="who received ribavirin (1), lopinavir (10, see Fig. 4 )-" exact="ritonavir" post="(2) and a corticosteroid had lower 21-day acute respiratory"/>
  <result pre="distress syndrome (ARDS) and death rates than those who received" exact="ribavirin" post="and a corticosteroid 54, 55 combination therapy using interferon"/>
  <result pre="corticosteroid alone (uncontrolled study) [56]. The use of the corticosteroid," exact="methylprednisolone" post="(3, Fig. 3) as a therapeutic intervention for SARS"/>
  <result pre="weeks 2-3 of the illness were higher in patients given" exact="hydrocortisone" post="(n = 10) than those given normal saline (n"/>
  <result pre="phase of the illness, suggesting that early use of pulsed" exact="methylprednisolone" post="(3) might prolong viremia. In the case of patients"/>
  <result pre="In the case of patients with MERS, the combination of" exact="ritonavir" post="(2) + interferon α2a or interferon α-2b resulted in"/>
  <result pre="on coronaviruses infections. Retrospective analyses showed that the combination of" exact="ritonavir" post="(2) + interferon β-1a had no significant effect on"/>
  <result pre="on clinical outcome [48]. In another study, the combination of" exact="ribavirin" post="(1), ritonavir (2) + interferon α-2a resolved viremia within"/>
  <result pre="outcome [48]. In another study, the combination of ribavirin (1)," exact="ritonavir" post="(2) + interferon α-2a resolved viremia within 2 days"/>
  <result pre="severe MERS. Patients with severe MERS who were treated with" exact="methylprednisolone" post="(3) with or without antivirals and interferons had no"/>
  <result pre="and dosing regimens. Drugs including interferon α, β, and γ," exact="ribavirin" post="(1) and inhibitors of cyclophilin 60, 61, 62 were"/>
  <result pre="discovered using this approach. The combination therapy of interferon and" exact="ribavirin" post="showed the best result in treating MERS-CoV infection. Also,"/>
  <result pre="Table 2[64]. They identified seven compounds (lycorine, emetine, monensin sodium," exact="mycophenolate mofetil," post="mycophenolic acid, phenazopyridine, and pyrvinium pamoate) from HTS screening"/>
  <result pre="They identified seven compounds (lycorine, emetine, monensin sodium, mycophenolate mofetil," exact="mycophenolic acid," post="phenazopyridine, and pyrvinium pamoate) from HTS screening as broad-spectrum"/>
  <result pre="protein synthesis 0.30 (2.69) 1.43 (3.63) 0.34 (3.08) 0.12 (3.51)" exact="Mycophenolate mofetil" post="Immune suppressant, antineoplastic, antiviral 1.58 (3.43) 0.23 (3.01) 1.54"/>
  <result pre="CoVs, de Wilde et al identified four drugs such as" exact="chloroquine" post="(7), chlorpromazine (8), loperamide (9) and lopinavir (10) from"/>
  <result pre="Wilde et al identified four drugs such as chloroquine (7)," exact="chlorpromazine" post="(8), loperamide (9) and lopinavir (10) from the screening"/>
  <result pre="al identified four drugs such as chloroquine (7), chlorpromazine (8)," exact="loperamide" post="(9) and lopinavir (10) from the screening of FDA"/>
  <result pre="drugs such as chloroquine (7), chlorpromazine (8), loperamide (9) and" exact="lopinavir" post="(10) from the screening of FDA approved drugs library"/>
  <result pre="[72] and other coronavirus SARS-CoV [73]. The mechanistic study of" exact="chlorpromazine" post="(8) on MERS-CoV indicated that it inhibited the virus"/>
  <result pre="on clathrin-mediated endocytosis was not only the sole antiviral mechanism." exact="Loperamide" post="(9), an antidiarrheal opioid receptor agonist, which reduces intestinal"/>
  <result pre="drugs were classified into different therapeutic groups as neurotransmitter inhibitors," exact="estrogen" post="receptor antagonists, kinase signaling inhibitors, protein-processing inhibitors, inhibitors of"/>
  <result pre="5 and the activities in Table 3 ). Antidiarrheal agent" exact="loperamide" post="(9), or anti-HIV-1 agent lopinavir (10) were able to"/>
  <result pre="Table 3 ). Antidiarrheal agent loperamide (9), or anti-HIV-1 agent" exact="lopinavir" post="(10) were able to inhibit both MERS-and SARS-CoVs infection"/>
  <result pre="20 and 29 μM, respectively [81]. Kinase signaling pathway inhibitors" exact="imatinib" post="mesylate (35) and dasatinib (36) are known inhibitors of"/>
  <result pre="respectively [81]. Kinase signaling pathway inhibitors imatinib mesylate (35) and" exact="dasatinib" post="(36) are known inhibitors of the Abelson murine leukemia"/>
  <result pre="Antiparasitic agent 7.41 15.55 Amodiaquinedihydrochloridedehydrate (21) Antiparasitic agent 6.21 1.27" exact="Loperamide" post="(9) Antidiarrheal agent 4.8 5.90 Lopinavir (10) HIV-1 inhibitor"/>
  <result pre="1.27 0.76 Gemcitabine hydrochloride (23) DNA metabolism inhibitor 1.21 4.95" exact="Tamoxifen" post="citrate (24) Estrogen receptor inhibitor 10.11 92.88 Toremifene citrate"/>
  <result pre="hydrochloride (23) DNA metabolism inhibitor 1.21 4.95 Tamoxifen citrate (24)" exact="Estrogen" post="receptor inhibitor 10.11 92.88 Toremifene citrate (25) Estrogen receptor"/>
  <result pre="1.21 4.95 Tamoxifen citrate (24) Estrogen receptor inhibitor 10.11 92.88" exact="Toremifene" post="citrate (25) Estrogen receptor inhibitor 12.91 11.96 Terconazole (26)"/>
  <result pre="citrate (24) Estrogen receptor inhibitor 10.11 92.88 Toremifene citrate (25)" exact="Estrogen" post="receptor inhibitor 12.91 11.96 Terconazole (26) Sterol metabolism inhibitor"/>
  <result pre="10.11 92.88 Toremifene citrate (25) Estrogen receptor inhibitor 12.91 11.96" exact="Terconazole" post="(26) Sterol metabolism inhibitor 12.20 15.32 Fluspirilene (27) Neurotransmitter"/>
  <result pre="inhibitor 12.91 11.96 Terconazole (26) Sterol metabolism inhibitor 12.20 15.32" exact="Fluspirilene" post="(27) Neurotransmitter inhibitor 7.47 5.96 Thiothixene (28) Neurotransmitter inhibitor"/>
  <result pre="metabolism inhibitor 12.20 15.32 Fluspirilene (27) Neurotransmitter inhibitor 7.47 5.96" exact="Thiothixene" post="(28) Neurotransmitter inhibitor 9.29 5.31 Fluphenazine hydrochloride (29) Neurotransmitter"/>
  <result pre="inhibitor 12.64 20.03 Triflupromazine hydrochloride (33) Neurotransmitter inhibitor 5.75 6.39" exact="Clomipramine" post="hydrochloride (34) Neurotransmitter inhibitor 9.33 13.23 Imatinibmesylate (35) Kinase"/>
  <result pre="that these drugs have potential as antiviral therapy against coronaviruses." exact="Toremifene" post="citrate (25) is an estrogen receptor 1 antagonist that"/>
  <result pre="as antiviral therapy against coronaviruses. Toremifene citrate (25) is an" exact="estrogen" post="receptor 1 antagonist that inhibits both MERS-CoV and SARS-CoV"/>
  <result pre="converts inosine monophosphate to guanosine monophosphate [83]. The active molecule," exact="mycophenolic acid" post="(46, see for structure Table 4 ), exhibits broad-spectrum"/>
  <result pre="virus (HBV), hepatitis C virus (HCV) and arboviruses [82]. Recently," exact="mycophenolic acid" post="was identified as a potential anti-MERS-CoV drug by a"/>
  <result pre="result as the treatment of MERS-CoV infected common marmosets with" exact="mycophenolic acid" post="had a worse outcome than untreated animals did [84]."/>
  <result pre="4 Compound Chemical structure IC50 (μM) Peptide cleavage DUB activity" exact="6-Mercaptopurine" post="(43) 26.9 25.8 6-Thioguanine (44) 24.4 12.4 N-Ethylmaleimide (45)"/>
  <result pre="zinc ion, and zinc conjugate inhibitors and naphthalene inhibitors [91]." exact="6-Mercaptopurine" post="(43), 6-thioguanine (44) and N-ethylmaleimide (45) as well as"/>
  <result pre="and zinc conjugate inhibitors and naphthalene inhibitors [91]. 6-Mercaptopurine (43)," exact="6-thioguanine" post="(44) and N-ethylmaleimide (45) as well as the immunosuppressive"/>
  <result pre="(44) and N-ethylmaleimide (45) as well as the immunosuppressive drug," exact="mycophenolic acid" post="(46), were all independently able to inhibit the proteolytic"/>
  <result pre="of MERS-CoV PLpro (Table 4) [92]. Compared with N-ethylmaleimide (45)," exact="6-mercaptopurine" post="(43), 6-thioguanine (44) were more effective inhibitors, while mycophenolic"/>
  <result pre="PLpro (Table 4) [92]. Compared with N-ethylmaleimide (45), 6-mercaptopurine (43)," exact="6-thioguanine" post="(44) were more effective inhibitors, while mycophenolic acid (46)"/>
  <result pre="(45), 6-mercaptopurine (43), 6-thioguanine (44) were more effective inhibitors, while" exact="mycophenolic acid" post="(46) was a less effective inhibitor against the MERS-CoV"/>
  <result pre="(46) was a less effective inhibitor against the MERS-CoV PLpro." exact="Disulfiram" post="(47, Fig. 8 ) is an FDA drug and"/>
  <result pre=") is an FDA drug and has been used in" exact="alcohol" post="aversion therapy. This drug was reported to inhibit the"/>
  <result pre="by reacting with cysteine residues, suggesting broad-spectrum characteristics [95]. Notably," exact="disulfiram" post="(47) has been reported as an allosteric inhibitor of"/>
  <result pre="combinations of interferon- α or-β with other antivirals such as" exact="ribavirin" post="and/or lopinavir-ritonavir have been used to treat patients with"/>
  <result pre="SARS or MERS. Overall, combination treatments consisting of interferons and" exact="ribavirin" post="did not consistently improve outcomes 47, 48, 49, 136,"/>
  <result pre="the T cell-mediated adaptive immune response [142]. The calcineurin inhibitor" exact="cyclosporine" post="(90, Fig. 13) inhibits a broad range of CoVs"/>
  <result pre="EC50/Cmax ratio at standard therapeutic dosages limit its clinical application." exact="Trametinib" post="(91), selumetinib (92), everolimus, rapamycin, dasatinib, and imatinib are"/>
  <result pre="clinical application. Trametinib (91), selumetinib (92), everolimus, rapamycin, dasatinib, and" exact="imatinib" post="are examples of inhibitors of kinase signaling pathways, which"/>
  <result pre="and SARS-CoV S-mediated cell-cell fusion in vitro[148]. Neurotransmitter inhibitors including" exact="chlorpromazine" post="(8), fluphenazine (29), and promethazine (30), were reported to"/>
  <result pre="crystallography and functional assays. Examples include the viroporin inhibitor hexamethylene" exact="amiloride" post="(6, Fig. 1), which reduces the ion channel activity"/>
  <result pre="and MERS-CoV viruses. Inosine monophosphate dehydrogenase (IMPDH) inhibitors such as" exact="ribavirin" post="and mycophenolic acid inhibit an important step in de"/>
  <result pre="viruses. Inosine monophosphate dehydrogenase (IMPDH) inhibitors such as ribavirin and" exact="mycophenolic acid" post="inhibit an important step in de novo synthesis of"/>
  <result pre="of two casesAntivir. Ther.202015879124831606 49ShalhoubS.IFN-α2a or IFN-β1a in combination with" exact="ribavirin" post="to treat Middle East respiratory syndrome coronavirus pneumonia: a"/>
  <result pre="of Middle East respiratorysyndromecoronavirus replication in cell cultureAntimicrobAgentsChemother58201448754884 66SavarinoA.Effects of" exact="chloroquine" post="on viral infections: an old drug against today’s diseases?Lancet"/>
  <result pre="C virus entry depends on clathrin-mediated endocytosisJ. Virol.8020066964697216809302 71PohjalaL.Inhibitors of" exact="alpha" post="virus entry and replication identiﬁed with as table Chikungunya"/>
  <result pre="action, and self-potentiationSemin. Oncol.221995310 78KangH.Synergistic antiviral activity of gemcitabine and" exact="ribavirin" post="against enterovirusesAntivir. Res.124201511026526589 79BrassA.L.The IFITM proteins mediate cellular resistance"/>
  <result pre="and inhibition by designed antiviral compoundsAntiviral Res.1152015213825554382 92ChengK.W.Thiopurine analogs and" exact="mycophenolic acid" post="synergistically inhibit the papain-like protease of Middle East respiratory"/>
  <result pre="pneumocytes against SARS coronavirus infection in macaquesNat. Med.10200429029314981511 131HartB.J.Interferon-β and" exact="mycophenolic acid" post="are potent inhibitors of Middle East respiratory syndrome coronavirus"/>
  <result pre="a first-in-class broad-spectrum antiviral agentAntiviral Res.11020149410325108173 133FalzaranoD.Treatment with interferon-α2b and" exact="ribavirin" post="improves outcome in MERS-CoV-infected rhesus macaquesNat. Med.1920131313131724013700 134CinatlJ.Treatment of"/>
  <result pre="induces severe in vitro cytopathology and is strongly inhibited by" exact="cyclosporin A" post="or interferon-α treatmentJ. Gen. Virol.9420131749176023620378 144TanakaY.Suppression of coronavirus replication"/>
  <result pre="of the SARS coronavirus envelope protein ion channelPLoS Pathog.52009e1000511 162WilsonL.Hexamethylene" exact="amiloride" post="blocks E protein ion channels and inhibits coronavirus replicationVirology353200629430616815524"/>
  <result pre="and HR2 domainsInt. J. Mol. Sci.192018487 169MorenoC.Efficacy and safety of" exact="simeprevir" post="with PegIFN/ribavirin in naïve or experienced patients infected with"/>
 </snippets>
</snippetsTree>
